TWD 63.0
(-10.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.12 Billion TWD | 3.99% |
2022 | 1.08 Billion TWD | 17.62% |
2021 | 923.18 Million TWD | 31.15% |
2020 | 703.89 Million TWD | 128.38% |
2019 | 308.2 Million TWD | 118.84% |
2018 | 140.83 Million TWD | 0.27% |
2017 | 140.45 Million TWD | 21.08% |
2016 | 116 Million TWD | 15.78% |
2015 | 100.19 Million TWD | -17.25% |
2014 | 121.07 Million TWD | -3.01% |
2013 | 124.83 Million TWD | 49.15% |
2012 | 83.69 Million TWD | 7.17% |
2011 | 78.1 Million TWD | 36.75% |
2010 | 57.11 Million TWD | 100.39% |
2009 | 28.5 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 164.67 Million TWD | -16.62% |
2024 Q2 | 186.62 Million TWD | -89.38% |
2023 Q1 | 261.08 Million TWD | -11.42% |
2023 Q2 | 285.88 Million TWD | 9.5% |
2023 FY | 714.93 Million TWD | -34.16% |
2023 Q3 | 275.84 Million TWD | -3.51% |
2023 Q4 | 197.51 Million TWD | -28.4% |
2022 Q3 | 308.68 Million TWD | 22.69% |
2022 Q1 | 230.78 Million TWD | -0.27% |
2022 FY | 1.08 Billion TWD | 17.62% |
2022 Q4 | 294.76 Million TWD | -4.51% |
2022 Q2 | 251.6 Million TWD | 9.02% |
2021 Q2 | 180.44 Million TWD | -36.05% |
2021 Q3 | 229.13 Million TWD | 26.98% |
2021 FY | 923.18 Million TWD | 31.15% |
2021 Q4 | 231.41 Million TWD | 1.0% |
2021 Q1 | 282.18 Million TWD | 38.01% |
2020 Q2 | 224 Million TWD | 54.91% |
2020 FY | 703.89 Million TWD | 128.38% |
2020 Q4 | 204.46 Million TWD | 56.29% |
2020 Q1 | 144.6 Million TWD | 6.16% |
2020 Q3 | 130.81 Million TWD | -41.6% |
2019 Q2 | 51.15 Million TWD | 36.4% |
2019 Q1 | 37.5 Million TWD | -8.78% |
2019 Q4 | 136.21 Million TWD | 63.45% |
2019 FY | 308.2 Million TWD | 118.84% |
2019 Q3 | 83.33 Million TWD | 62.91% |
2018 Q4 | 41.11 Million TWD | -8.39% |
2018 Q1 | 27.54 Million TWD | -26.96% |
2018 Q2 | 27.29 Million TWD | -0.89% |
2018 Q3 | 44.88 Million TWD | 64.41% |
2018 FY | 140.83 Million TWD | 0.27% |
2017 Q2 | 33.11 Million TWD | -3.71% |
2017 FY | 140.45 Million TWD | 21.08% |
2017 Q4 | 37.71 Million TWD | 7.03% |
2017 Q3 | 35.23 Million TWD | 6.39% |
2017 Q1 | 34.39 Million TWD | -7.18% |
2016 Q4 | 37.05 Million TWD | 29.37% |
2016 Q3 | 28.64 Million TWD | -0.46% |
2016 Q2 | 28.77 Million TWD | 33.59% |
2016 Q1 | 21.53 Million TWD | -30.52% |
2016 FY | 116 Million TWD | 15.78% |
2015 Q3 | 21.7 Million TWD | -11.77% |
2015 Q2 | 24.59 Million TWD | 7.43% |
2015 Q1 | 22.89 Million TWD | -55.64% |
2015 FY | 100.19 Million TWD | -17.25% |
2015 Q4 | 30.99 Million TWD | 42.83% |
2014 Q4 | 51.61 Million TWD | 68.51% |
2014 FY | 121.07 Million TWD | -3.01% |
2014 Q3 | 30.62 Million TWD | 57.31% |
2014 Q2 | 19.46 Million TWD | 0.52% |
2014 Q1 | 19.36 Million TWD | -56.23% |
2013 Q3 | 23.58 Million TWD | -32.38% |
2013 Q4 | 44.25 Million TWD | 87.6% |
2013 FY | 124.83 Million TWD | 49.15% |
2013 Q2 | 34.88 Million TWD | 57.72% |
2013 Q1 | 22.11 Million TWD | -15.44% |
2012 Q3 | 18.03 Million TWD | -8.33% |
2012 Q4 | 26.15 Million TWD | 45.0% |
2012 Q1 | 19.86 Million TWD | -27.53% |
2012 FY | 83.69 Million TWD | 7.17% |
2012 Q2 | 19.67 Million TWD | -0.97% |
2011 FY | 78.1 Million TWD | 36.75% |
2011 Q1 | 15.81 Million TWD | 35.21% |
2011 Q2 | 14.05 Million TWD | -11.15% |
2011 Q3 | 20.81 Million TWD | 48.07% |
2011 Q4 | 27.41 Million TWD | 31.74% |
2010 Q2 | 16.7 Million TWD | 64.94% |
2010 FY | 57.11 Million TWD | 100.39% |
2010 Q4 | 11.7 Million TWD | -37.05% |
2010 Q1 | 10.12 Million TWD | 0.0% |
2010 Q3 | 18.58 Million TWD | 11.27% |
2009 FY | 28.5 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -343117.933% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | -784.458% |
Level Biotechnology Inc. | 151.99 Million TWD | -642.92% |
Sagittarius Life Science Corp | 135.85 Million TWD | -731.183% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | -1388.534% |
TaiMed Biologics Inc. | 225.23 Million TWD | -401.342% |
GlycoNex Incorporation | 995 Thousand TWD | -113386.131% |
VBI | 32.55 Million TWD | -3368.552% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | -339.596% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | -481.498% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -2353.528% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -841.695% |
Visgeneer Inc. | 67.48 Million TWD | -1573.316% |
Mycenax Biotech Inc. | -375.19 Million TWD | 400.963% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | -121.368% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -1667.033% |
Neith Corporation | 66.87 Million TWD | -1588.554% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 21.804% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -3747.053% |
Enimmune corporation | 220.1 Million TWD | -413.029% |
TaiRx, Inc. | 217.13 Million TWD | -420.042% |
CHO Pharma, Inc. | 268.99 Million TWD | -319.775% |
EirGenix Inc. | 236.74 Million TWD | -376.971% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -982.105% |
Sunny Pharmtech Inc. | 357.62 Million TWD | -215.749% |
Lin BioScience, Inc. | 1.09 Billion TWD | -2.95% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | -324.253% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -2182.523% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -104164.728% |
Lukas Biomedical Inc. | 177.45 Million TWD | -536.341% |
RBC Bioscience Corporation | 58.35 Million TWD | -1834.997% |
BiOptic Inc. | 108.69 Million TWD | -938.887% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -1254552.222% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -1528.244% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -43081.147% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | -75.362% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -1109.809% |
NaviFUS Corp. | 11.82 Million TWD | -9447.535% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | -492.037% |
Sinew Pharma Inc. | 186.25 Million TWD | -506.265% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -1425.454% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | -412.34% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -2622.179% |
AP Biosciences Inc | 32.25 Million TWD | -3401.029% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 38.977% |
3D Global Biotech Inc. | 5.27 Million TWD | -21310.447% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | -255.847% |
Intech Biopharm Corporation | -163.99 Million TWD | 788.55% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -2622.113% |
TWi Biotechnology, Inc. | 169.55 Million TWD | -565.967% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | -668.039% |
TCI GENE Inc. | 174.61 Million TWD | -546.665% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -6273161.111% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | -275.222% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | -288.094% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -1245.151% |
PharmaEngine, Inc. | 441.78 Million TWD | -155.594% |
Savior Lifetec Corporation | 223.36 Million TWD | -405.525% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | -336.352% |
OBI Pharma, Inc. | 2.01 Billion TWD | 43.997% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | -713.125% |
Acepodia, Inc. | 452.56 Million TWD | -149.507% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | -108.746% |